Over 90 nutritionists have hit back at Ozempic maker Novo Nordisk's project to update the Nova classification for ...

It is midday in Nairobi's Central Business District. I stroll downtown to see how easy it is to buy Ozempic, a drug sold in the Kenyan market as semaglutide and approved for diabetes but that is ...

Could taking tiny fractions of the normal prescribed dose of a medication offer a brilliant way to benefit from the drug, ...

Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the obesity treatment market.

Anthropic on Monday closed its latest funding round at a $61.5 billion post-money valuation, the company confirmed to CNBC.

Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration ...

Though the Healthy Skepticism ads don’t specifically call out compounded GLP-1s, Lilly said in a statement to MM+M that ...

A medical device company has secured investment from the owner of the developer of Ozempic and a private equity firm, to ...

Novo Nordisk launched "My Ozempic ®  Era" today, a national campaign which spotlights the longstanding Ozempic ®  patient ...

AbbVie on Monday jumped into the hot weight-loss space, looking to gain ground on its Big Pharma peers, with a licensing deal ...